Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: A clinical and FDOPA-PET study

Parkinsonism and Related Disorders

Volumn 14, Issue 3, 2008, Pages 224-228

  van Beilen, Marije ^a   Portman, Axel T ^a   Kiers, Henk A L ^b   Maguire, Ralph P ^a   Kaasinen, Valtteri ^a   Koning, Marthe ^a   Pruim, Jan ^a   Leenders, Klaus L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Cognition; FDOPA PET; Parkinson; Striatum

Indexed keywords

6 FLUORODOPA F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; MALE; MEMORY; MENTAL FUNCTION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SCORING SYSTEM; VERBAL BEHAVIOR; VERBAL FLUENCY;

AGED; COGNITION; CORPUS STRIATUM; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; LEVODOPA; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PROBLEM SOLVING; VERBAL LEARNING;

EID: 41449101694     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.08.011     Document Type: Article

References (27)

1. Lang A.E., and Lozano A.M. Parkinson's disease. First of two parts. NEJM 339 (1998) 1044-1053
2. Schapira A.H.V. Parkinson's disease. Science, medicine, and the future. Br Med J 318 (1999) 311-314
3. Dubois B., and Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 244 (1997) 2-8
4. Green J., McDonald W.M., Vitek J.L., Evatt M., Freeman A., Haber M., et al. Cognitive impairments in advanced PD without dementia. Neurology 59 (2002) 1320-1324
5. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9 (1986) 357-381
6. Leenders K.L., Salmon E.P., Tyrell Perani P., Brooks D.J., Sager H., Jones H., et al. The nigrostriatal system assessed in vivo by positron emission tomography in healthy volunteers and patients with Parkinson's disease. Arch Neurol 47 (1990) 1290-1298
7. Antonini A., Vontobel P., Psylla M., Gunther I., Maguire P.R., Missimer J., et al. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Arch Neurol 52 (1995) 1183-1190
8. Marié R.M., Barré L., Dupuy B., Viader F., Defer G., and Baron J.C. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 260 (1998) 77-80
9. Defer G.L., Widner H., Marie R.M., et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Dis 14 (1999) 572-584
10. Fahn S., and Elton R.L. Members of the UPDRS development committee. Unified Parkinson's disease rating scale. In: Fahn S., Marsden C.D., Calne D.B., and Goldstein M. (Eds). Recent developments in Parkinson's disease (2000), MacMillan, NJ
11. Friston K.J. Commentary and opinion. 2. Statistical Parametric Mapping-ontology and current issues. J Cer Blood Flow Met 15 (1995) 361-370
12. Talairach J., and Tournoux P. Co-planar stereotactic atlas of the human brain (1998), Thieme Medical Publishers, New York
13. Dhawan V., Ma Y., Pillai V., Spetsieris P., Chaly T., Belakhlef A., et al. Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach. J Nucl Med 43 (2002) 1324-1330
14. Efron B., and Tibshirani R. Emperical bayes methods and false discovery rates for microarrays. Genet Epidemiol 23 (2002) 70-86
15. Bäckman L., Robins-Wahlin T.B., Lundin A., et al. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 20 (1997) 2207-2217
16. Fuh H.J., and Wang S.J. Caudate hemorrage: clinical features, neuropsychological assessments and radiological findings. Clin Neurol Neurosurg (1995) 296-299
17. Postle B.R., and D'Esposito M. Dissociation of human caudate nucleus activity in spatial and nonspatial working memory: an event-related fMRI study. Brain Res 16 (1999) 107-115
18. Marié R.M., Barré L., Dupuy B., Viader F., Defer G., and Baron J.C. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 260 (1998) 77-80
19. Brück A., Portin R., Lindell A., Laihinen A., Bergman J., Haaparata M., et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 311 (2002) 81-84
20. 18F]Fluorodopa positron emission tomographic study. Arch Neurol 57 (2000) 470-475
21. Holthoff-Detto V.A., Kessler J., Herholz K., Bönner H., Pietrzyk U., Würker M., et al. Funcional effects of striatal dysfunction in Parkinson disease. Arch Neurol 54 (1997) 145-150
22. 18F]F-dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci 166 (1999) 141-151
23. Lozza C., Baron J.C., Eidelberg D., Mentis M.J., Carbon M., and Marie. Executive processes in Parkinson's diseaese: FDG-PET and network analysis. Hum Brain Mapping 22 (2004) 236-245
24. 123I]β-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J Neural Transmission 107 (2000) 303-319
25. Karnath H., Himmelbach M., and Rorden C. The subcortical anatomy of human spatial neglect: putamen, caudate nucleus and pulvinar. Brain 125 (2002) 350-360
26. Troyer A.K., Black S.E., Armilio M.L., and Moscovitch M. Cognitive and motor functioning in a patient with selective infarction of the left basal ganglia: evidence for decreased non-routine response selection and performance. Neuropsychologia 42 (2003) 902-911
27. Monchi O., Petrides M., Petre V., Worsley K., and Dagher A. Wisconsin card sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci 21 (2001) 7733-7741